Skip to main content
Erschienen in: Clinical Rheumatology 3/2019

29.10.2018 | Original Article

Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease

verfasst von: Heikki Relas, Silja Kosola

Erschienen in: Clinical Rheumatology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Across diagnosis groups, transition of adolescents and young adults from children’s hospitals to adult care associates with decreased treatment adherence and suboptimal treatment results. Our aim was to compare the health-related quality of life (HRQoL) and disease activity of juvenile idiopathic arthritis (JIA) patients after the transfer of care to the adult clinic and adult patients in the same outpatient clinic.

Methods

All consecutive JIA patients aged 16 to 20 years who visited the transition clinic between September 2016 and August 2017 and all consecutive adult onset arthritis patients between December 2016 and August 2017 in the rheumatology outpatient clinic of Helsinki University Hospital were evaluated. HRQoL was measured by a generic instrument, 15D.

Results

A total of 291 patients, 130 JIA, and 161 adults were identified with respective median disease durations of 6.5 and 4.0 years. Adults had lower HRQoL measured by 15D (median 0.90 vs. 0.96, P < 0.001) and higher Disease Activity Score 28 (DAS28) than JIA patients (median 2.4 vs. 1.6, P < 0.001). Adults smoked more frequently than JIA patients (22% vs. 7%, P < 0.001). In multiple regression, female gender, smoking, disease activity, and obesity were associated with poorer HRQoL. Smoking adults had more active disease (DAS28 median 3.1 vs. 2.1, P = 0.031) and lower HRQoL (15D median 0.86 vs. 0.93, P < 0.001) than non-smoking adults.

Conclusions

Transition phase JIA patients had acceptable HRQoL and lower disease activity than patients with adult onset rheumatic diseases with similar disease duration. Smoking was associated with more active disease and lower HRQoL.
Literatur
2.
Zurück zum Zitat Berntson L, Andersson Gare B, Fasth A et al (2003) Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 30:2275–2282PubMed Berntson L, Andersson Gare B, Fasth A et al (2003) Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 30:2275–2282PubMed
3.
Zurück zum Zitat Hersh A, von Scheven E, Yelin E, Medscape (2011) Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7:290–295 Hersh A, von Scheven E, Yelin E, Medscape (2011) Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7:290–295
4.
Zurück zum Zitat Coulson EJ, Hanson HJ, Foster HE (2014) What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatology (Oxford) 53:2155–2166CrossRef Coulson EJ, Hanson HJ, Foster HE (2014) What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatology (Oxford) 53:2155–2166CrossRef
5.
Zurück zum Zitat Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809–2818CrossRefPubMed Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809–2818CrossRefPubMed
6.
Zurück zum Zitat Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D'elia H (2013) Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 40:715–724CrossRefPubMed Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D'elia H (2013) Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 40:715–724CrossRefPubMed
7.
Zurück zum Zitat Elhai M, Bazeli R, Freire V, Feydy A, Drape JL, Quartier P, Kahan A, Deslandre C, Wipff J (2013) Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood. J Rheumatol 40:520–527CrossRefPubMed Elhai M, Bazeli R, Freire V, Feydy A, Drape JL, Quartier P, Kahan A, Deslandre C, Wipff J (2013) Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood. J Rheumatol 40:520–527CrossRefPubMed
8.
Zurück zum Zitat Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M, HUS QoL Study Group (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 29:267–273CrossRefPubMed Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M, HUS QoL Study Group (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 29:267–273CrossRefPubMed
9.
Zurück zum Zitat Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K (2016) Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS One 11:e0153267CrossRefPubMedPubMedCentral Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K (2016) Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS One 11:e0153267CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767–775CrossRefPubMed Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767–775CrossRefPubMed
11.
Zurück zum Zitat Tollisen A, Selvaag AM, Aulie HA et al (2017) Physical functioning, pain and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year follow-up study. Arthritis Care Res (Hoboken) Tollisen A, Selvaag AM, Aulie HA et al (2017) Physical functioning, pain and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year follow-up study. Arthritis Care Res (Hoboken)
12.
Zurück zum Zitat Wipff J, Sparsa L, Lohse A, Quartier P, Kahan A, Deslandre CJ (2016) Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies. Joint Bone Spine 83:69–74CrossRefPubMed Wipff J, Sparsa L, Lohse A, Quartier P, Kahan A, Deslandre CJ (2016) Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies. Joint Bone Spine 83:69–74CrossRefPubMed
14.
Zurück zum Zitat Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM, Society for Adolescent Medicine (2003) Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health 33:309–311CrossRefPubMed Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM, Society for Adolescent Medicine (2003) Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health 33:309–311CrossRefPubMed
15.
Zurück zum Zitat Tucker LB, Cabral DA (2007) Transition of the adolescent patient with rheumatic disease: issues to consider. Rheum Dis Clin N Am 33:661–672CrossRef Tucker LB, Cabral DA (2007) Transition of the adolescent patient with rheumatic disease: issues to consider. Rheum Dis Clin N Am 33:661–672CrossRef
18.
Zurück zum Zitat Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L (2017) EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis 76:639–646CrossRefPubMed Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L (2017) EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis 76:639–646CrossRefPubMed
19.
Zurück zum Zitat Relas H, Luosujarvi R, Kosola S (2018) Outcome of transition phase patients with juvenile idiopathic arthritis. Mod Rheumatol:1–6 Relas H, Luosujarvi R, Kosola S (2018) Outcome of transition phase patients with juvenile idiopathic arthritis. Mod Rheumatol:1–6
20.
Zurück zum Zitat Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed
21.
Zurück zum Zitat Aletaha D, Smolen JS (2006) The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am 32:9–44 vii CrossRef Aletaha D, Smolen JS (2006) The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am 32:9–44 vii CrossRef
22.
Zurück zum Zitat Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRefPubMed Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRefPubMed
23.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed
25.
Zurück zum Zitat Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336CrossRefPubMed Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336CrossRefPubMed
26.
27.
Zurück zum Zitat Horneff G, Burgos-Vargas R (2009) Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 27:S131–S138PubMed Horneff G, Burgos-Vargas R (2009) Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 27:S131–S138PubMed
28.
Zurück zum Zitat Davies R, Gaynor D, Hyrich KL, Pain CE (2017) Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum 46:584–593CrossRefPubMed Davies R, Gaynor D, Hyrich KL, Pain CE (2017) Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum 46:584–593CrossRefPubMed
29.
Zurück zum Zitat Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460CrossRefPubMedPubMedCentral Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54CrossRefPubMed Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54CrossRefPubMed
33.
Zurück zum Zitat Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF, for the SWEFOT Trial Investigators Group (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469–475CrossRefPubMed Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF, for the SWEFOT Trial Investigators Group (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469–475CrossRefPubMed
34.
Zurück zum Zitat Saevarsdottir S, Wedren S, Seddighzadeh M et al (2011) Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum 63:26–36CrossRefPubMed Saevarsdottir S, Wedren S, Seddighzadeh M et al (2011) Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum 63:26–36CrossRefPubMed
35.
Zurück zum Zitat Goldenberg M, Danovitch I, IsHak WW (2014) Quality of life and smoking. Am J Addict 23:540–562CrossRefPubMed Goldenberg M, Danovitch I, IsHak WW (2014) Quality of life and smoking. Am J Addict 23:540–562CrossRefPubMed
38.
Zurück zum Zitat Aaltonen KJ, Sokka T, Mottonen T et al (2014) A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scand J Rheumatol 43:286–290CrossRefPubMed Aaltonen KJ, Sokka T, Mottonen T et al (2014) A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scand J Rheumatol 43:286–290CrossRefPubMed
Metadaten
Titel
Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease
verfasst von
Heikki Relas
Silja Kosola
Publikationsdatum
29.10.2018
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 3/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4351-4

Weitere Artikel der Ausgabe 3/2019

Clinical Rheumatology 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.